Received Apr 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
chronic kidney disease; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A patient (age and gender not provided) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for Covid-19 Immunization, reaction(s): "fine"; Bnt162b2 (DOSE 2, SINGLE), for Covid-19 Immunization, reaction(s): "fine". The following information was reported: CHRONIC KIDNEY DISEASE (medically significant), outcome "unknown". The event "chronic kidney disease" required physician office visit. Therapeutic measures were taken as a result of chronic kidney disease. The booster shot gave to the patient chronic kidney disease and it was confirmed by a physician at this point. The patient was required to get kidney infusions twice a year. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.